ABCB5 and melanoma: Originally, ABCB5 was characterized on CD133+ human epidermal melanocyte progenitor cells, acting as a negative regulator of cell differentiation, and on human malignant melanoma cells, serving as a chemoresistance-conferring drug efflux transporter [9].